ADB-BINACA
http://dbpedia.org/resource/ADB-BINACA an entity of type: Thing
ADB-BINACA is a cannabinoid designer drug that has been found as an ingredient in some synthetic cannabis products. It was originally developed by Pfizer as a potential analgesic, and is a potent agonist of the CB1 receptor with a binding affinity (Ki) of 0.33 nM and an EC50 of 14.7 nM.
rdf:langString
rdf:langString
ADB-BINACA
rdf:langString
ADB-BUTINACA
xsd:integer
69554439
xsd:integer
1103738379
xsd:integer
18
21
xsd:integer
1185282
2682867
xsd:integer
57621565
81407832
rdf:langString
ADB-BUTINACA
xsd:integer
24
26
rdf:langString
N-[-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-benzyl-1H-indazole-3-carboxamide
rdf:langString
N-[-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-butyl-1H-indazole-3-carboxamide
rdf:langString
NpSG
rdf:langString
Class B
rdf:langString
Schedule I
xsd:integer
4
xsd:integer
2
xsd:integer
129406620
xsd:integer
155907792
rdf:langString
O=CC1=NNC2=C1C=CC=C2
rdf:langString
O=CC1=NNC3=C1C=CC=C3
xsd:integer
1
rdf:langString
GPWADXHYJAZPAX-OAHLLOKOSA-N
rdf:langString
IUFIUAWRCUVUCQ-UHFFFAOYSA-N
rdf:langString
PUVP61SOSI
rdf:langString
ADB-BINACA is a cannabinoid designer drug that has been found as an ingredient in some synthetic cannabis products. It was originally developed by Pfizer as a potential analgesic, and is a potent agonist of the CB1 receptor with a binding affinity (Ki) of 0.33 nM and an EC50 of 14.7 nM.
rdf:langString
Schedule II
xsd:nonNegativeInteger
7599
xsd:string
1185282-27-2
xsd:string
2682867-55-4
xsd:string
PUVP61SOSI
xsd:string
129406620
xsd:string
155907792